The p16 (CDKN2A) gene is involved in the growth of neuroblastoma cells and its expression is associated with prognosis of neuroblastoma patients
β Scribed by Takita, Junko; Hayashi, Yasuhide; Nakajima, Takashi; Adachi, Jun-ichi; Tanaka, Takeo; Yamaguchi, Naohito; Ogawa, Yoshihiro; Hanada, Ryoji; Yamamoto, Keiko; Yokota, Jun
- Book ID
- 110061701
- Publisher
- Nature Publishing Group
- Year
- 1998
- Tongue
- English
- Weight
- 522 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0950-9232
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Paraffin sections from 190 epithelial ovarian tumours, including 159 malignant and 31 benign epithelial tumours, were analysed immunohistochemically for expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product p16 INK4A (p16). Most benign tumours showed no p16 expression in the tumour
The cyclin-dependent kinase inhibitor 2A/multiple tumor suppressor gene 1 (CDKN2A/MTS1/p16) plays an important role in the control of progression from G 1 to S-phase of the cell cycle through the inhibition of CDK4-mediated RB1 phosphorylation. In this study we investigated 46 nonfunctional pituitar